心脉医疗(688016.SH)：第二期已累计回购122.87万股公司股份

Core Viewpoint - The company, Xinmai Medical (688016.SH), has announced its share repurchase program, indicating a commitment to enhancing shareholder value through stock buybacks [1] Summary by Relevant Sections - Share Repurchase Details - As of August 31, 2025, the company has repurchased a total of 1.2287 million shares through the Shanghai Stock Exchange's centralized bidding system in the second phase of its buyback program [1] - The highest price paid for the repurchased shares was 120.00 RMB per share, while the lowest price was 84.26 RMB per share [1] - The total amount spent on the repurchase was 129 million RMB, excluding transaction fees such as stamp duty and commissions [1]